Preclinical Studies Suggest FTY720 Mechanisms In Multiple Sclerosis May Include Direct Activity In The Brain Medical News Today Sat, 12 May 2007 2:04 AM PDT New preclinical data, presented at the American Academy of Neurology (AAN) annual meeting in Boston, reflect the expanding understanding of FTY720's (fingolimod) mechanism of action in multiple sclerosis (MS), suggesting direct beneficial effects in the brain. [click link for full article] |
Multiple Sclerosis Research: 2007 Charcot Award Winner: Professor Alastair Compston PhD, FRCP Medical News Today Fri, 11 May 2007 12:08 PM PDT I feel very honoured, and am profoundly grateful to the many colleagues who participated in our research over the last 30 years, the patients who made much of that work possible, and Multiple Sclerosis International Federation for recognising these contributions through the 2007 Charcot Award. [click link for full article] |
Groups work with researchers, drug cos. AP via Yahoo! News Fri, 11 May 2007 2:40 PM PDT A major effort is under way in medical research circles to shave years off the time it takes for discoveries by scientists to be converted into treatments for patients. |
Disease Sufferers Lobby at Biotech Conference RedNova Fri, 11 May 2007 8:14 PM PDT BOSTON _ Patients offer poignant reminders of the high stakes involved in connecting the biotechnology dots. After all, for them it's a matter of life and death. |
Inmate with MS too sick to be sentenced
New Kerala Fri, 11 May 2007 8:25 PM PDT
DELAND, Fla., May 11: A Florida man convicted of leaving the scene after he struck and killed a skateboarding teen remains in jail, too sick to be sentenced.
0 Comments:
Post a Comment
<< Home